Healthcare provider profile · identity verified

Calvin Moy, MD

Family Practice · PONTIAC, IL · NPI 1154558732

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	176
Levothyroxine Sodium	Levothyroxine Sodium	296	72
Losartan Potassium	Losartan Potassium	239	71
Amlodipine Besylate	Amlodipine Besylate	237	77
Omeprazole	Omeprazole	231	67
Lisinopril	Lisinopril	211	68
Pantoprazole Sodium	Pantoprazole Sodium	205	67
Tamsulosin Hcl	Tamsulosin Hcl	194	51
Metoprolol Succinate	Metoprolol Succinate	191	62
Trazodone Hcl	Trazodone Hcl	178	35
Gabapentin	Gabapentin	168	47
Hydrochlorothiazide	Hydrochlorothiazide	166	53
Metformin Hcl Er	Metformin Hcl	154	47
Potassium Chloride	Potassium Chloride	151	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	41
Citalopram Hbr	Citalopram Hydrobromide	123	32
Pravastatin Sodium	Pravastatin Sodium	123	35
Sertraline Hcl	Sertraline Hcl	117	36
Allopurinol	Allopurinol	107	30
Lorazepam	Lorazepam	107	29
Metformin Hcl	Metformin Hcl	106	36
Alprazolam	Alprazolam	104	26
Rosuvastatin Calcium	Rosuvastatin Calcium	102	38
Fluticasone Propionate	Fluticasone Propionate	100	27
Furosemide	Furosemide	99	31
Tramadol Hcl	Tramadol Hcl	92	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	24
Simvastatin	Simvastatin	88	30
Meloxicam	Meloxicam	85	26
Spironolactone	Spironolactone	85	11
Eliquis	Apixaban	74	24
Prednisone	Prednisone	69	63
Famotidine	Famotidine	68	21
Valsartan	Valsartan	68	24
Albuterol Sulfate Hfa	Albuterol Sulfate	66	21
Carvedilol	Carvedilol	60	18
Fenofibrate	Fenofibrate	60	18
Zolpidem Tartrate	Zolpidem Tartrate	60	13
Tizanidine Hcl	Tizanidine Hcl	59	11
Glipizide	Glipizide	56	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	56	14
Finasteride	Finasteride	55	suppressed
Glipizide Er	Glipizide	55	19
Fluoxetine Hcl	Fluoxetine Hcl	54	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	29
Amoxicillin	Amoxicillin	49	38
Clopidogrel	Clopidogrel Bisulfate	48	14
Escitalopram Oxalate	Escitalopram Oxalate	48	13
Duloxetine Hcl	Duloxetine Hcl	47	12
Metoprolol Tartrate	Metoprolol Tartrate	47	18
Tradjenta	Linagliptin	47	suppressed
Atenolol	Atenolol	41	15
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Azithromycin	Azithromycin	40	35
Montelukast Sodium	Montelukast Sodium	40	12
Warfarin Sodium	Warfarin Sodium	39	11
Ezetimibe	Ezetimibe	38	suppressed
Januvia	Sitagliptin Phosphate	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	11
Bupropion Xl	Bupropion Hcl	33	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	24
Ozempic	Semaglutide	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Jantoven	Warfarin Sodium	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Baclofen	Baclofen	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Cephalexin	Cephalexin	24	19
Indapamide	Indapamide	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Rybelsus	Semaglutide	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nystatin	Nystatin	15	11
Terazosin Hcl	Terazosin Hcl	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	13
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Promethazine Hcl	Promethazine Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Diazepam	Diazepam	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Naproxen	Naproxen	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error